Notably, BC consists of human epidermal growth factor receptor 2 (HER2) overexpression, luminal A, luminal B, and subtypes of triple-negative breast cancer (TNBC) (Zhu et al., 2022). Here, ERBB2 is linked to triple-negative breast carcinoma.